Jade Biosciences Statistics
NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.31+0.25 (+1.66%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Jade Biosciences by the numbers
Jade Biosciences has a market capitalization of $1.06 billion based on 69.19M shares outstanding. With trailing EPS of $-1.83, Jade Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% above its 50-day average and 15.9% below its 200-day average.
Average daily trading volume is 917.21K shares, or about $14.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
JBIO valuation vs. peer median
| Metric | JBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.06B | $1.02B | +3% |
| Avg. volume | 917.21K | 620.37K | +48% |
Peer median across 8 companies: NKTR, CTY, ANRO, KARD, OMER, AAPG, SPTX, CYRX.
Valuation
- Market cap
- $1.06B
- EPS (TTM)
- $-1.83
- Shares outstanding
- 69.19M
Price and trading
- Previous close
- 15.06
- Open
- 15.00
- Day range
- 15.00 – 15.53
- 52-week range
- 11.32 – 28.00
- 52-week change
- +27.58%
- Beta
- —
- Volume
- 1.02M
- Average volume
- 917.21K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 1.06B
- Forward Pe
- -6.78
- Eps
- -1.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.00
- Week52 Low
- 11.32
- Avg Volume
- 917.21K
- Shares Outstanding
- 69.19M
- Ma50
- 14.95
- Ma200
- 18.21
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -45.32%
- Pct From52w Low
- 35.25%